• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
An integrative sparse boosting analysis of cancer genomic commonality and difference.癌症基因组共性与差异的整合稀疏增强分析
Stat Methods Med Res. 2020 May;29(5):1325-1337. doi: 10.1177/0962280219859026. Epub 2019 Jul 7.
2
Robust nonparametric integrative analysis to decipher heterogeneity and commonality across subgroups using sparse boosting.使用稀疏提升对亚组进行稳健的非参数综合分析,以破译异质性和共性。
Stat Med. 2022 Apr 30;41(9):1658-1687. doi: 10.1002/sim.9322. Epub 2022 Jan 24.
3
Revealing genomic heterogeneity and commonality: A penalized integrative analysis approach accounting for the adjacency structure of measurements.揭示基因组异质性和共性:一种考虑测量邻接结构的惩罚性综合分析方法。
Genet Epidemiol. 2024 Apr;48(3):114-140. doi: 10.1002/gepi.22549. Epub 2024 Feb 5.
4
Identification of breast cancer prognosis markers using integrative sparse boosting.使用整合稀疏提升法鉴定乳腺癌预后标志物。
Methods Inf Med. 2012;51(2):152-61. doi: 10.3414/ME11-02-0019. Epub 2012 Feb 20.
5
Promoting similarity of model sparsity structures in integrative analysis of cancer genetic data.在癌症遗传数据的综合分析中促进模型稀疏结构的相似性。
Stat Med. 2017 Feb 10;36(3):509-559. doi: 10.1002/sim.7138. Epub 2016 Sep 25.
6
Identification of cancer omics commonality and difference via community fusion.通过社区融合来识别癌症组学的共性和差异。
Stat Med. 2019 Mar 30;38(7):1200-1212. doi: 10.1002/sim.8027. Epub 2018 Nov 12.
7
Identification of cancer genomic markers via integrative sparse boosting.通过集成稀疏提升识别癌症基因组标记物。
Biostatistics. 2012 Jul;13(3):509-22. doi: 10.1093/biostatistics/kxr033. Epub 2011 Oct 31.
8
Integrative analysis of multiple cancer genomic datasets under the heterogeneity model.基于异质性模型的多种癌症基因组数据集的综合分析。
Stat Med. 2013 Sep 10;32(20):3509-21. doi: 10.1002/sim.5780. Epub 2013 Mar 21.
9
Sparse multiple co-Inertia analysis with application to integrative analysis of multi -Omics data.稀疏多重共惯性分析及其在多组学数据综合分析中的应用。
BMC Bioinformatics. 2020 Apr 15;21(1):141. doi: 10.1186/s12859-020-3455-4.
10
Robust semiparametric gene-environment interaction analysis using sparse boosting.使用稀疏提升进行稳健的半参数基因-环境交互作用分析。
Stat Med. 2019 Oct 15;38(23):4625-4641. doi: 10.1002/sim.8322. Epub 2019 Jul 29.

引用本文的文献

1
Bayesian Modeling of Cancer Outcomes Using Genetic Variables Assisted by Pathological Imaging Data.利用病理影像数据辅助的基因变量对癌症预后进行贝叶斯建模
Stat Med. 2025 Feb 10;44(3-4):e10350. doi: 10.1002/sim.10350.
2
Biomarker-guided heterogeneity analysis of genetic regulations via multivariate sparse fusion.基于多元稀疏融合的遗传调控标志物指导异质性分析。
Stat Med. 2021 Jul 30;40(17):3915-3936. doi: 10.1002/sim.9006. Epub 2021 Apr 27.

本文引用的文献

1
Adenosine Deaminase 1 as a Biomarker for Diagnosis and Monitoring of Patients with Acute Lymphoblastic Leukemia.腺苷脱氨酶1作为急性淋巴细胞白血病患者诊断和监测的生物标志物
J Med Biochem. 2018 Apr 1;37(2):128-133. doi: 10.1515/jomb-2017-0042. eCollection 2018 Apr.
2
Identification of cancer omics commonality and difference via community fusion.通过社区融合来识别癌症组学的共性和差异。
Stat Med. 2019 Mar 30;38(7):1200-1212. doi: 10.1002/sim.8027. Epub 2018 Nov 12.
3
Promoting Similarity of Sparsity Structures in Integrative Analysis with Penalization.在惩罚性整合分析中促进稀疏结构的相似性
J Am Stat Assoc. 2017;112(517):342-350. doi: 10.1080/01621459.2016.1139497. Epub 2017 May 3.
4
Epithelial-mesenchymal transition and GALC expression of circulating tumor cells indicate metastasis and poor prognosis in non-small cell lung cancer.循环肿瘤细胞的上皮-间充质转化和 GALC 表达预示着非小细胞肺癌的转移和不良预后。
Cancer Biomark. 2018;22(3):417-426. doi: 10.3233/CBM-170995.
5
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.起源细胞模式主导了 33 种癌症类型的 10000 个肿瘤的分子分类。
Cell. 2018 Apr 5;173(2):291-304.e6. doi: 10.1016/j.cell.2018.03.022.
6
A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers.妇科和乳腺癌的全面泛癌分子研究。
Cancer Cell. 2018 Apr 9;33(4):690-705.e9. doi: 10.1016/j.ccell.2018.03.014. Epub 2018 Apr 2.
7
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.癌症基因组图谱对肾细胞癌的全面分子特征分析。
Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075.
8
A possible new target in lung-cancer cells: The orphan receptor, bombesin receptor subtype-3.一种可能的肺癌细胞新靶点:孤儿受体,蛙皮素受体亚型 3。
Peptides. 2018 Mar;101:213-226. doi: 10.1016/j.peptides.2018.01.016. Epub 2018 Feb 2.
9
Sparse boosting for high-dimensional survival data with varying coefficients.稀疏提升在高维变系数生存数据中的应用。
Stat Med. 2018 Feb 28;37(5):789-800. doi: 10.1002/sim.7544. Epub 2017 Nov 19.
10
Identification and validation of novel prognostic markers in Renal Cell Carcinoma.肾细胞癌中新型预后标志物的鉴定与验证
Dan Med J. 2017 Oct;64(10).

癌症基因组共性与差异的整合稀疏增强分析

An integrative sparse boosting analysis of cancer genomic commonality and difference.

作者信息

Sun Yifan, Sun Zhengyang, Jiang Yu, Li Yang, Ma Shuangge

机构信息

Center for Applied Statistics, School of Statistics, Renmin University of China, Beijing, China.

School of Public Health, University of Memphis, Tennessee, USA.

出版信息

Stat Methods Med Res. 2020 May;29(5):1325-1337. doi: 10.1177/0962280219859026. Epub 2019 Jul 7.

DOI:10.1177/0962280219859026
PMID:31282286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7471599/
Abstract

In cancer research, high-throughput profiling has been extensively conducted. In recent studies, the integrative analysis of data on multiple cancer patient groups/subgroups has been conducted. Such analysis has the potential to reveal the genomic commonality as well as difference across groups/subgroups. However, in the existing literature, methods with a special attention to the genomic commonality and difference are very limited. In this study, a novel estimation and marker selection method based on the sparse boosting technique is developed to address the commonality/difference problem. In terms of technical innovation, a new penalty and computation of increments are introduced. The proposed method can also effectively accommodate the grouping structure of covariates. Simulation shows that it can outperform direct competitors under a wide spectrum of settings. The analysis of two TCGA (The Cancer Genome Atlas) datasets is conducted, showing that the proposed analysis can identify markers with important biological implications and have satisfactory prediction and stability.

摘要

在癌症研究中,高通量分析已被广泛开展。在最近的研究中,对多个癌症患者组/亚组的数据进行了综合分析。这种分析有可能揭示不同组/亚组之间的基因组共性和差异。然而,在现有文献中,特别关注基因组共性和差异的方法非常有限。在本研究中,开发了一种基于稀疏提升技术的新型估计和标记选择方法来解决共性/差异问题。在技术创新方面,引入了一种新的惩罚和增量计算方法。所提出的方法还可以有效地适应协变量的分组结构。模拟表明,在广泛的设置下,它优于直接竞争对手。对两个TCGA(癌症基因组图谱)数据集进行了分析,结果表明所提出的分析能够识别具有重要生物学意义的标记,并且具有令人满意的预测能力和稳定性。